Changes after publication

Changes after publication

February 2014: implementation section updated to clarify that naftidrofuryl oxalate is recommended as an option for treating people with intermittent claudication who have peripheral arterial disease. Additional minor maintenance update also carried out.

March 2012: minor maintenance

  • National Institute for Health and Care Excellence (NICE)